NDC 70625-300

Fosaprepitant

Fosaprepitant Dimeglumine

Fosaprepitant is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sungen Pharma, Llc. The primary component is Fosaprepitant Dimeglumine.

Product ID70625-300_56007c44-405f-496a-8422-77d7161ac443
NDC70625-300
Product TypeHuman Prescription Drug
Proprietary NameFosaprepitant
Generic NameFosaprepitant Dimeglumine
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2019-11-05
Marketing CategoryANDA / ANDA
Application NumberANDA211624
Labeler NameSunGen Pharma, LLC
Substance NameFOSAPREPITANT DIMEGLUMINE
Active Ingredient Strength150 mg/5mL
Pharm ClassesNeurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 70625-300-01

1 VIAL, SINGLE-DOSE in 1 CARTON (70625-300-01) > 5 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2019-11-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70625-300-01 [70625030001]

Fosaprepitant INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA211624
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-11-05

Drug Details

Active Ingredients

IngredientStrength
FOSAPREPITANT DIMEGLUMINE150 mg/5mL

Pharmacological Class

  • Neurokinin 1 Antagonists [MoA]
  • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 3A4 Inducers [MoA]

NDC Crossover Matching brand name "Fosaprepitant" or generic name "Fosaprepitant Dimeglumine"

NDCBrand NameGeneric Name
0338-0008FosaprepitantFosaprepitant Dimeglumine
0591-4385Fosaprepitantfosaprepitant
0781-3497FosaprepitantFosaprepitant
16714-120FosaprepitantFosaprepitant
16714-248FosaprepitantFosaprepitant dimeglumine
16714-929FosaprepitantFosaprepitant
16729-240FosaprepitantFOSAPREPITANT
25021-784FosaprepitantFosaprepitant Dimeglumine
31722-165FosaprepitantFosaprepitant dimeglumine
43598-859FosaprepitantFosaprepitant
43598-948FosaprepitantFosaprepitant
60505-6105FosaprepitantFosaprepitant
63323-972FosaprepitantFOSAPREPITANT
67457-889fosaprepitantfosaprepitant
67457-888fosaprepitantfosaprepitant
69539-034FosaprepitantFosaprepitant
70625-300FosaprepitantFosaprepitant
72205-026FosaprepitantFosaprepitant
71839-104fosaprepitantfosaprepitant
68001-421FosaprepitantFosaprepitant
71288-418FOSAPREPITANTFOSAPREPITANT
70860-780FosaprepitantFosaprepitant
69097-830fosaprepitantfosaprepitant
72606-569FosaprepitantFosaprepitant
69539-181FosaprepitantFosaprepitant
70710-1615fosaprepitantfosaprepitant
72205-054FosaprepitantFosaprepitant
70860-782FosaprepitantFosaprepitant
72603-106FOSAPREPITANTFOSAPREPITANT
68180-690FosaprepitantFosaprepitant
0006-3061EMENDFOSAPREPITANT DIMEGLUMINE
0006-3941EMENDFOSAPREPITANT DIMEGLUMINE
0143-9384FOSAPREPITANT DIMEGLUMINEFOSAPREPITANT DIMEGLUMINE
0143-9428FOSAPREPITANT DIMEGLUMINEFOSAPREPITANT DIMEGLUMINE
0781-3484fosaprepitant dimegluminefosaprepitant dimeglumine
55150-299FOSAPREPITANT DIMEGLUMINEFOSAPREPITANT DIMEGLUMINE
59651-523FOSAPREPITANT DIMEGLUMINEFOSAPREPITANT DIMEGLUMINE
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.